A detailed history of Nordwand Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Nordwand Advisors, LLC holds 250 shares of PFE stock, worth $6,865. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 250 -0.0%
Holding current value
$6,865
Previous $7 Million 3.43%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$25.26 - $29.6 $5,052 - $5,920
-200 Reduced 44.44%
250 $7 Million
Q1 2024

May 06, 2024

BUY
$25.89 - $29.73 $6,472 - $7,432
250 Added 125.0%
450 $12.5 Million
Q3 2023

Oct 27, 2023

BUY
$32.09 - $37.51 $6,418 - $7,502
200 New
200 $6.63 Million
Q1 2023

May 04, 2023

SELL
$39.39 - $51.28 $2.17 Million - $2.83 Million
-55,195 Reduced 55.25%
44,709 $1.82 Billion
Q4 2022

Jan 26, 2023

BUY
$41.75 - $54.5 $4.17 Million - $5.44 Million
99,904 New
99,904 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nordwand Advisors, LLC Portfolio

Follow Nordwand Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordwand Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nordwand Advisors, LLC with notifications on news.